Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease
Journal of Gastroenterology and Hepatology · 18.10.2026
DOI: 10.1111/jgh.70826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 18.10.2026. Verfasst von Donghee Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Aim
We investigated whether accelerometer‐assessed moderate‐to‐vigorous physical activity (MVPA) is associated with cardiovascular mortality among individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) in the United States.
Methods
We performed a longitudinal analysis using the 2003–2006 US National Health and Nutrition Examination Survey data among adults, with mortality follow‐up through December 2019. We defined MASLD primarily using the Hepatic Steatosis Index (HSI), followed by current cardiometabolic criteria; we used the US Fatty Liver Index (USFLI) in sensitivity analyses. We classified accelerometer‐assessed PA as MVPA, total PA, and sedentary behavior.
Results
Among 2785 individuals with HSI‐defined MASLD, 584 deaths occurred, including 198 cardiovascular deaths, over a median follow‐up of 14.7 years. A higher level of PA is associated with a more favorable predicted cardiovascular risk profile at baseline. Among individuals with MASLD, increasing MVPA was nonlinearly associated with reduced all‐cause mortality in a multivariable model (hazard ratio [HR]: 0.80, 95% CI: 0.71–0.91 per 10‐min increase; P for trend < 0.001). Furthermore, higher MVPA was nonlinearly associated with a lower risk of cardiovascular mortality in MASLD (HR: 0.72, 95% CI: 0.53–0.99 per 10‐min increase; P for trend = 0.009). Although higher total PA was also associated with reduced mortality, the point estimate was substantially weaker than that observed for MVPA. Sensitivity analyses using the USFLI definition showed directionally similar but attenuated associations. Increased sedentary behavior did not impact mortality in the MASLD group.
Conclusions
Higher MVPA is nonlinearly associated with cardiovascular mortality in individuals with MASLD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
- Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Division of Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Medicine, Bridgeport Hospital, Yale New Haven Health, Bridgeport, Connecticut, USA.
- Division of Gastroenterology & Hepatology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
ORCID-Profile: Donghee Kim, Pojsakorn Danpanichkul, Do Han Kim, Donghyun Ko, Karn Wijarnpreecha, Aijaz Ahmed
Zitieren
APA
Kim, D., Danpanichkul, P., Kim, D. H., Ko, D., Wijarnpreecha, K., & Ahmed, A. (2026). Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70826
Vancouver
Kim D, Danpanichkul P, Kim DH, Ko D, Wijarnpreecha K, Ahmed A. Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70826
BibTeX
@article{Kim2026,
author = {Kim, Donghee and Danpanichkul, Pojsakorn and Kim, Do Han and Ko, Donghyun and Wijarnpreecha, Karn and Ahmed, Aijaz},
title = {Impact of Physical Activity on Cardiovascular Outcomes in Metabolic Dysfunction‐Associated Steatotic Liver Disease},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70826}
}
EUVIMED